SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-010213
Filing Date
2024-04-03
Accepted
2024-04-03 20:49:49
Documents
1
Period of Report
2024-03-15

Document Format Files

Seq Description Document Type Size
1 form4-04042024_120440.html 4  
1 form4-04042024_120440.xml 4 3745
  Complete submission text file 0001415889-24-010213.txt   5159
Mailing Address
Business Address
DIXON WENDY L (Reporting) CIK: 0001202283 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39200 | Film No.: 24821269

Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)